Cornerstone Planning Group’s West Pharmaceutical WST Stock Holding History

Cornerstone Planning Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-104	Closed	-$37.3K	–	1732
2026 Q2	$37.3K	Sell	104 -1	-1%	-$306	﹤0.01%	477
2026 Q1	$32.2K	Buy	105 +50	+91%	+$12.4K	﹤0.01%	524
2025 Q4	$13K	Sell	55 -2	-4%	-$547	﹤0.01%	718
2025 Q3	$601	Sell	57 -24	-30%	-$5.83K	﹤0.01%	1435
2025 Q2	$19.3K	Sell	81 -22	-21%	-$4.7K	﹤0.01%	426
2025 Q1	$22.5K	Sell	103 -7	-6%	-$1.93K	0.01%	388
2024 Q4	$38K	Buy	110 +40	+57%	+$12.6K	0.01%	217
2024 Q3	$22.3K	Sell	70 -2	-3%	-$612	0.01%	286
2024 Q2	$21.7K	Sell	72 -58	-45%	-$20.5K	0.01%	301
2024 Q1	$47.5K	Sell	130 -35	-21%	-$12.9K	0.01%	179
2023 Q4	$58.1K	Hold	165	–	–	0.02%	166
2023 Q3	$61.9K	Sell	165 -5	-3%	-$1.93K	0.02%	155
2023 Q2	$65K	Buy	+170	New	+$60.7K	0.03%	201
2022 Q4	$61.1K	Buy	+240	New	+$56.9K	0.03%	235

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Cornerstone Planning Group's WST Position: Q3 2026 in Review

Cornerstone Planning Group sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 104 shares — an estimated $37.3K sold.

Cornerstone Planning Group first reported a position in WST in Q4 2022 and held it in 14 quarters. The position peaked at $65K in Q2 2023. 175 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Cornerstone Planning Group reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Cornerstone Planning Group sold 104 West Pharmaceutical shares in Q3 2026, an estimated $37.3K.
Cornerstone Planning Group first reported a position in West Pharmaceutical in Q4 2022 and held it in 14 quarters.
Cornerstone Planning Group's West Pharmaceutical position peaked at $65K in Q2 2023.
175 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.